Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 69 | 0 | 10 | 0 | €854.30 | €883.50 | 3.418% |
| Vertex Pharmaceuticals Inc. | 59 | 2 | 7 | 0 | €440.80 | €450.36 | 2.170% |
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 9 | 0 | €1,079.0 | €1,091.9 | 1.198% |
| Insmed Inc. | 46 | 0 | 6 | 0 | €68.50 | €77.41 | 13.013% |
| Alnylam Pharmace. | 45 | 0 | 7 | 0 | €252.60 | €275.25 | 8.967% |
| Neurocrine Bioscience | 44 | 0 | 9 | 0 | €111.30 | €149.74 | 34.534% |
| Johnson & Johnson | 40 | 1 | 4 | 0 | €147.58 | €187.62 | 27.128% |
| Acadia Pharmaceuticals | 35 | 1 | 7 | 0 | €14.13 | €29.92 | 111.790% |
| AbbVie Inc. | 34 | 0 | 3 | 0 | €175.92 | €180.90 | 2.833% |
| Merck & Co. Inc. | 32 | 1 | 4 | 0 | €105.80 | €125.78 | 18.884% |
| Intra-Cellular Therapies Inc. | 31 | 0 | 3 | 0 | €66.00 | €84.73 | 28.376% |
| Jazz Pharmaceuticals plc | 30 | 0 | 6 | 0 | €104.70 | €183.41 | 75.181% |
| Cytokinetics Inc. | 30 | 1 | 1 | 0 | €50.00 | €84.22 | 68.446% |
| Amgen Inc. | 28 | 0 | 3 | 0 | €296.45 | €304.82 | 2.823% |
| Pfizer Inc. | 31 | 4 | 6 | 0 | €25.88 | €41.47 | 60.278% |
| United Therapeutics | 27 | 1 | 5 | 1 | €323.60 | €332.33 | 2.699% |